HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ochratoxin B

structure given in first source

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Frank, Marian: 1 article (02/2019)
2.	Hamacher, Alexandra: 1 article (02/2019)
3.	Kassack, Matthias U: 1 article (02/2019)
4.	Lin, Wenhan: 1 article (02/2019)
5.	Liu, Zhen: 1 article (02/2019)
6.	Müller, Werner E G: 1 article (02/2019)
7.	Proksch, Peter: 1 article (02/2019)
8.	Özkaya, Ferhat Can: 1 article (02/2019)
9.	Agnihotri, Amit: 1 article (09/2014)
10.	Chatopadhyay, Pronobesh: 1 article (09/2014)

Related Diseases

1.	Mitochondrial Diseases (Mitochondrial Disease) 09/01/2014 - "We examined the mechanism by which the ochratoxin B induced interaction with calcium-channel antagonist verapamil and mitochondrial dysfunction of the rat trachea in vitro experiment. " 09/01/2014 - "Synergism of ochratoxin B and calcium-channel antagonist verapamil caused mitochondrial dysfunction."
2.	Kidney Neoplasms (Kidney Cancer) 01/01/1991 - "No prominent difference in distribution patterns was found that could explain why the rat is the animal most susceptible to ochratoxin A-induced renal cancer or why ochratoxin B is less toxic than ochratoxin A."
3.	Hepatocellular Carcinoma (Hepatoma) 02/01/1989 - "Influence of ochratoxin B on the ochratoxin A inhibition of phenylalanyl-tRNA formation in vitro and protein synthesis in hepatoma tissue culture cells."
4.	Carcinoma (Carcinomatosis) 02/03/2019 - "Viomellein (9) and ochratoxin B (18) exhibited strong cytotoxicity against the A2780 human ovarian carcinoma cells with IC50 values of 5.0 and 3.0 µM, respectively."

Related Drugs and Biologics

1.	ochratoxin A
2.	Verapamil (Calan)
3.	Transfer RNA (tRNA)
4.	Proteins (Proteins, Gene)
5.	Calcium Channel Blockers (Blockers, Calcium Channel)
6.	viomellein